Latest current assets for 300255.SZ: $1.6B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest current assets for 300255.SZ is $1.6B as of September 2026. That compares with $2.1B in the prior-year period — down 22.1% year over year. Investors often review this figure alongside Hebei Changshan Biochemical Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, 300255.SZ's current assets moved from $2.1B to $1.6B — a 22.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Hebei Changshan Biochemical Pharmaceutical , Ltd.'s operating scale or balance-sheet position.
A current assets figure of $1.6B for 300255.SZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting 300255.SZ's current assets ($1.6B), review year-over-year change from $2.1B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Hebei Changshan Biochemical Pharmaceutical , Ltd.'s current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.